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INTRODUCTION
Coronary subclavian steal (CSS) syndrome is a rare 
complication of coronary artery bypass graft surgery 
(CABG) involving the left internal mammary artery (LIMA) 
graft to the left anterior descending (LAD) artery. 
It results from stenosis of the left subclavian artery 
proximal to the LIMA, which compromises myocardial 
blood flow. The incidence of CSS syndrome is between 
0.1-3.4% in the United States.1  Most cases occur as a 
result of long-standing subclavian stenosis due to 
progres-sion of the stenosis following CABG. We report 
a case of CSS syndrome, which presented as a non-ST 
elevation myocardial infarction (NSTEMI). 
CASE PRESENTATION
A 76 year-old male with a past medical history of 
hypertension, coronary artery disease, myocardial 
infarction in 2007, left carotid artery stenosis, stroke in 
2009, and end-stage renal disease on hemodialysis 
presented to the emergency department with two weeks 
of exertional chest pain, worsening fatigue and shortness 
of breath. On the morning of presentation, he developed 
chest pain at rest and came to the emergency department. 
This patient was treated for myocardial infarction with a 
three-vessel CABG in 2007: he had a LIMA graft to the 
LAD, and saphenous vein grafts to the obtuse marginal 
artery, and posterior descending artery. 
On physical examination, he was found to be tachypneic, 
tachycardic and hypoxic. Electrocardiogram revealed ST 
segment depressions in the anterolateral leads and his 
troponins were ele-vated at 2.81ng/dL. The patient was 
admitted to the hospital for NSTEMI and was started on 
aspirin, atorvastatin, metoprolol and a heparin infusion.
An echocardiogram revealed akinesis of the apex, 
anterior septum, mid to distal inferior septum, mid to 
distal anterolateral wall, distal inferior wall and mid to 
distal inferolateral wall, all of which were not present on 
an echocardiogram performed the previous month. 
A subsequent cardiac catheterization revealed a patent 
LIMA, however it showed significant stenosis of the left 
subcla-vian artery proximal to the origin of the LIMA. 
Although all the findings of the echocardiogram could 
not be explained by the catheterization findings, the 
decision was made to intervene. Angioplasty and stenting 
of the left subclavian artery was performed, and this 
resulted in complete resolution of his symptoms. The ST 
segment normalized. Repeat echocardiogram revealed 
mild to moderation left ventricular function with ejection 
fraction of 40%. 
DISCUSSION  
This case highlights the difficulties that can arise in the 
treatment of CSS syndrome, particularly when it is unclear 
whether the pattern of ischemia is caused by the stenosis 
of the subclavian artery. In this case, the defects on 
echocardiogram pointed to flow limitation in the territory 
of the left main coronary artery. However, angiography 
revealed a patent left main. There was stenosis of the left 
subclavian artery leading to flow limitation to the distal 
LAD. Based on these findings, it was unclear whether the 
patient’s symptoms were caused by CSS syndrome.
Modalities of treatment of CSS syndrome include medical 
therapy alone, percutaneous intervention, and surgical 
revascularization. The success rate for angioplasty and 
stent placement to the subclavian artery is 80-100%.2,3 
Complication rates are reported to be between 3-6%, 
with the major complication being distal embolization.2 
The rate of instent restenosis is reported to be between 
3-6% at 20 months.2  In contrast, surgical options such 
as carotid to subclavian bypass have morbidity rates 
between 15-33%, and mortality between 5-8%.4 
Currently, there are no randomized clinical trials 
comparing the efficacy of one strategy versus another. 
However, most agree that in the setting of symptoms, 
surgical or endovascular therapy is indicated.5  
In a retrospective study, Schillinger et al compared 
patients treated with endovascular intervention to those 
treated with medical therapy alone. The study found that 
patients with ischemic symptoms were more likely to be 
intervened on, and asymptomatic patients were likely to 
be treated medically. However, there was no significant 
difference in the number of patients with symptomatic 
disease at the time of follow-up between both groups. 
They concluded that in the absence of symptoms, 
patients should not be intervened on based on 
hemodynamic findings alone.6   
For our patient, the decision was made to intervene using 
percutaneous transluminal angioplasty and stenting 
based on the presence of symptoms and stenosis of the 
subclavian artery. He did well post-procedure and 
reported remission of his symptoms. Ischemic findings 
on his ECG resolved and repeat echocardiogram showed 
improvement of the left ventricular function.  
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KEY POINTS
• Coronary subclavian steal (CSS) syndrome is a rare 
complication of coronary artery bypass graft (CABG) 
involving the left internal mammary artery (LIMA) 
graft to the left anterior descending (LAD) artery.  
• Though CSS is rare but not uncommon; therefore, 
it should be included in the differential diagnosis in 
patients with CABG presenting with chest pain.  
• Modalities of treatment include medical therapy 
alone, percutaneous intervention, and surgical 
revascularization. 
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